Advanced Medical Solutions Group (AMS.L) saw significant share activity on 27th October 2026, with its adviser and joint broker handling transactions totalling over 320,000 ordinary shares in a single session.
Investec Bank Plc (INVP.L, INL.JO) disclosed the trading activity on 28th October 2026 through a regulatory filing submitted under Rule 8.5 of the UK Takeover Code.
The bank purchased 70,793 ordinary shares in Advanced Medical Solutions, with prices ranging between 282.05p and 282.25p per share during the trading session.
On the selling side, Investec offloaded a considerably larger block of 250,000 ordinary shares, all executed at a uniform price of 282.25p per unit.
The combined volume across both sides of the activity underscores notable market interest in Advanced Medical Solutions at a time when Takeover Code disclosure obligations are in effect.
Investec occupies a dual role in relation to Advanced Medical Solutions, serving simultaneously as financial adviser and joint broker to the medical technology company, a position that requires heightened transparency under the Code.
Because of that connection, Investec must file as an exempt principal trader with recognised intermediary status, confirming it dealt in a client-serving capacity rather than on a proprietary basis.
The filing confirmed that no cash-settled derivative transactions, stock-settled derivatives, or options were involved in the reported activity, keeping the disclosure straightforward in scope.
Investec also stated that no indemnity arrangements, option agreements, or understandings relating to voting rights or future acquisitions of Advanced Medical Solutions securities exist in connection with this disclosure.
The filing was prepared by Gary Darch and submitted to a Regulatory Information Service in compliance with the public disclosure requirements that Rule 8 of the Takeover Code mandates for all parties operating in this capacity.
Rule 8.5 filings are a standard transparency mechanism under the UK’s merger and acquisition regulatory framework, designed to ensure market participants can monitor trading by connected intermediaries throughout an offer period.
The Takeover Panel’s Market Surveillance Unit oversees compliance with these dealing disclosure requirements, providing a point of consultation for firms navigating the obligations that arise during active offer situations.
